Collections

This file is in the following collections:

Expanding Access to COVID-19 Tests through US Postal Service Facilities Open Access (recommended)

Singh B, Risanger S, Morton D, Pignone M, Meyers LA. Expanding Access to COVID-19 Tests through US Postal Service Facilities. Medical Decision Making. 2021;41(1):3-8.

Descriptions

Resource type(s)

Article

Keyword

COVID-19
optimization
testing
underserved populations
USPS

Rights

Attribution-NonCommercial 3.0 United States

Creator

Singh, Bismark
Risanger, Simon
Morton, David
Pignone, Michael
Meyers, Lauren Ancel

Abstract

Widespread, convenient access to COVID-19 testing has been challenging in the United States. We make a case for provisioning COVID-19 tests through the United States Postal Service (USPS) facilities and demonstrate a simple method for selecting locations to improve access. We provide quantitative evidence that even a subset of USPS facilities could provide broad access, particularly in remote and at-risk communities with limited access to health care. Based on daily travel surveys, census data, locations of USPS facilities, and an established care-seeking model, we estimate that more than 94% of the US population would be willing to travel to an existing USPS facility if warranted. For half of the US population, this would require traveling less than 2.5 miles from home; for 90%, the distance would be less than 7 miles. In Georgia, Illinois, and Minnesota, we estimate that testing at USPS facilities would provide access to an additional 4.1, 3.1, and 1.3 million people and reduce the median travel distance by 3.0, 0.8, and 1.2 miles, respectively, compared with existing testing sites per 28 July 2020. We also discuss the option of distributing test-at-home kits via USPS instead of private carriers. Finally, our proposal provides USPS an opportunity to increase revenues and expand its mission, thus improving its future prospects and relevance.

Related URL

 https://journals.sagepub.com/doi/10.1177/0272989X20969690

Publisher

SAGE PUBLICATIONS INC

Date Created

2021-01

Original Identifier

(PMID) 33124494

Grants and funding

NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01 AI151176] Funding Source: Medline; NCIRD CDC HHS [U01 IP001136] Funding Source: Medline

DOI

10.1177/0272989X20969690

File Details

File Properties

Mime type: application/pdf

File size: 196.8 kB